Show simple item record

dc.contributor.authorSegura Carretero, Antonio 
dc.contributor.authorCuriel, Jose Antonio
dc.date.accessioned2019-04-04T12:32:10Z
dc.date.available2019-04-04T12:32:10Z
dc.date.issued2018-09-24
dc.identifier.citationSegura Carretero, A.; Curiel, J.A. Current Disease-Targets for Oleocanthal as Promising Natural Therapeutic Agent. Int. J. Mol. Sci. 2018, 19, 2899; doi:10.3390/ijms19102899.es_ES
dc.identifier.issn1422-0067
dc.identifier.urihttp://hdl.handle.net/10481/55347
dc.description.abstractThe broad number of health benefits which can be obtained from the long-term consumption of olive oil are attributed mainly to its phenolic fraction. Many olive oil phenolics have been studied deeply since their discovery due to their bioactivity properties, such as Hydroxytyrosol. Similarly, in the last decade, the special attention of researchers has been addressed to Oleocanthal (OC). This olive oil phenolic compound has recently emerged as a potential therapeutic agent against a variety of diseases, including cancer, inflammation, and neurodegenerative and cardiovascular diseases. Recently, different underlying mechanisms of OC against these diseases have been explored. This review summarizes the current literature on OC to date, and focuses on its promising bioactivities against different disease-targets.es_ES
dc.description.sponsorshipThis work was supported by the project of Spanish Ministry of Science and Innovation (AGL2015-67995-C3-2-R).es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectOleocanthales_ES
dc.subjectPhenolic compoundses_ES
dc.subjectOlive oil es_ES
dc.subjectTherapeutic propertieses_ES
dc.titleCurrent Disease-Targets for Oleocanthal as Promising Natural Therapeutic Agentes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES


Files in this item

[PDF]

This item appears in the following Collection(s)

Show simple item record

Atribución 3.0 España
Except where otherwise noted, this item's license is described as Atribución 3.0 España